Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
ACR Appropriateness Criteria Crohn Disease
David H. Kim
, Laura R. Carucci
, Mark E. Baker
, Brooks D. Cash
, Jonathan R. Dillman
, Barry W. Feig
, Kathryn J. Fowler
, Kenneth L. Gage
, Richard B. Noto
, Martin P. Smith
, Vahid Yaghmai
,
Judy Yee
, Tasneem Lalani
Research output
:
Contribution to journal
›
Article
›
peer-review
40
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ACR Appropriateness Criteria Crohn Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Crohn's Disease
100%
ACR Appropriateness Criteria
100%
Clinical Scenarios
66%
Guideline Development
33%
Gastrointestinal Tract
33%
Disease Process
33%
Inflammation
33%
Pediatric Population
33%
Treatment Methods
33%
Remission
33%
Histologic
33%
Imaging Modalities
33%
Nuclear Medicine
33%
Expert Opinion
33%
Medical Literature
33%
Imaging Procedures
33%
Chronic Inflammatory Diseases
33%
Clinical Conditions
33%
Structural Damage
33%
Clinical Laboratory
33%
Fluoroscopy
33%
Adult Population
33%
Evidence-based Guidelines
33%
Ultrasound CT
33%
Peer-reviewed Journals
33%
Expert Panel
33%
Consensus Building
33%
Radiography
33%
Modified Delphi Method
33%
Guideline Review
33%
Imaging Appropriateness
33%
Conventional CT
33%
MR Enterography
33%
CT Enterography
33%
Clinical Situations
33%
Multidisciplinary Experts
33%
Extensive Analysis
33%
Medicine and Dentistry
Crohn's Disease
100%
Pediatrics
33%
Disease Process
33%
Inflammatory Disorder
33%
Endoscopy
33%
Fluoroscopy
33%
Maturation
33%
Gastrointestinal Tract
33%
Narrative
33%
Magnetic Resonance Enterography
33%
Computed Tomography Enterography
33%
Diseases
33%
Nuclear Medicine
33%
Inflammation
33%
Radiography
33%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Diseases
100%
Inflammation
33%
Remission
33%